Vitura acquires Candor Medical

Open PDF
Stock Vitura Health Ltd (VIT.ASX)
Release Time 12 Feb 2025, 9:08 a.m.
Price Sensitive Yes
 Vitura acquires Candor Medical, a leading medicinal cannabis clinic business
Key Points
  • Vitura acquires Candor Medical, one of Australia's leading medicinal cannabis clinic businesses
  • Candor has around 15,000 active patients and over $1 million in EBITDA
  • The acquisition expands Vitura's specialty clinics division and telehealth offerings
Full Summary

Vitura Health Limited (ASX: VIT), a leading digital health platform business, has entered into a Share Purchase Agreement to acquire Livelihood Health Pty Ltd and its associated companies, which collectively provide innovative prescription treatments, including access to medicinal cannabis, through telehealth consultations under the 'Candor Medical' brand. Candor Medical was founded in 2022 and is one of Australia's leading and best-known medicinal cannabis clinic businesses, providing consultation services to around 15,000 patients and resulting in nearly $30 million in annual medication purchases via pharmacies. In FY2024, the consolidated unaudited EBITDA for the Candor group was in excess of $1 million, while in the first half of FY2025 alone, the EBITDA increased materially to more than $1 million (unaudited). The acquisition is being funded via a Private Placement to one of Australia's most successful businessmen, Professor Khalil (Charlie) Shahin AO. The acquisition of Candor catapults Vitura into one of the country's largest medicinal cannabis clinic providers, immediately expanding the consolidated consultation numbers to over 100,000 annually. Vitura's CEO, Geoff Cockerill, said the acquisition is a great opportunity to bring together two leaders in the field, both of whom have a deep alignment on the commitment to providing patients with personalised care and which reinforces Vitura's goal to make specialty healthcare product and service verticals more accessible to millions of patients across Australia.

Guidance

The acquisition of Candor is expected to deliver a significant increase in earnings per share for Vitura Health Limited post the placement of shares to Professor Shahin.

Outlook

The acquisition of Candor is expected to unlock significant opportunities for Vitura Health Limited, as it combines the large patient base of Doctors on Demand, the personalised approach of Candor, and Vitura's deep pharmacy and distribution network, which is expected to be a game changer in the Australian digital health landscape.